Letter to the editorHigh sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases
Section snippets
Acknowledgments
We cordially thank Prof. Jan Lubinski and his associates (Pomeranian Medical University, Szczecin, Poland) for inspiring discussions related to this investigation. This study was supported by Russian Foundation of Basic Research (grants 07-04-92282, 07-04-00172, 07-04-00122, and 09-04-90402) and by the government of Moscow (grant 15/09).
References (11)
- et al.
Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer
Clin Oncol (R Coll Radiol)
(2009) - et al.
Dramatic response to platinum in a patient with cancer with a germline BRCA2 mutation
Clin Oncol (R Coll Radiol)
(2009) - et al.
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Breast Cancer Res Treat
(2009) - et al.
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia
Fam Cancer
(2007) - et al.
Medscape. Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer
Nat Rev Clin Oncol
(2009)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2010 Elsevier Inc. All rights reserved.